Streetbeat News

Analyst Ratings

PTCT

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on PTC Therapeutics (NASDAQ:PTCT) and maintained a $73 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:27 pm

ROST

UBS analyst Jay Sole maintains a 'Sell' rating on Ross Stores (NASDAQ:ROST) and raises the price target from $78 to $80.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 07, 2023 | 1:26 pm

CAG

K

KMB

The most accurate Wall Street analysts have recommended holding three high-yielding stocks in the consumer staples sector: Kellogg Company (K), Kimberly-Clark Corporation (KMB), and Conagra Brands, Inc. (CAG). These stocks have dividend yields of 3.62%, 3.67%, and 4.31% respectively. Recent financial reports show that Kellogg beat analyst consensus on Q2 FY23 organic sales, while Kimberly-Clark and Conagra Brands slightly missed their sales estimates.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 1:25 pm

NSSC

Craig-Hallum analyst Chad Bennett initiates coverage on NAPCO Security Techs (NASDAQ:NSSC) with a Buy rating and announces a price target of $50.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:25 pm

TJX

UBS analyst Manav Gupta has maintained a Neutral rating on TJX Companies (NYSE:TJX) and raised the price target from $80 to $88.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 07, 2023 | 1:24 pm

EQH

Barclays analyst Theresa Chen maintains an Overweight rating on Equitable Hldgs (NYSE:EQH) and raises the price target from $31 to $33.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:24 pm

FTRE

B of A Securities has initiated coverage on Fortrea Holdings (NASDAQ:FTRE) with an Underperform rating and a price target of $27.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:23 pm

EPAM

Barclays analyst Ramsey El-Assal has maintained an Equal-Weight rating on EPAM Systems (NYSE:EPAM) and raised the price target from $250 to $265.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:22 pm

MESO

Maxim Group analyst Jason McCarthy has downgraded Mesoblast (NASDAQ:MESO) from Buy to Hold.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 1:21 pm

DINO

UBS analyst Manav Gupta maintains a Neutral rating on HF Sinclair (NYSE:DINO) and raises the price target from $53 to $58.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 07, 2023 | 1:21 pm